The Prevelance Rate of Human Cytomegalovirus (HCMV), Epstein-Barr Virus (EBV) and Human Herpes Virus (HHV-6) in a Saliva of the Patient With Periodantitis

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01248598

Enrollment

Registered

2010-11-25

Start date

2010-10-31

Completion date

Unknown

Last updated

2010-11-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cytomegalovirus, Epstein-Barr Virus Infections, Herpesvirus Infection

Brief summary

The purpose of this study is to study the prevalence of EBV, HCMV, HHV-6 in saliva and on the toothbrush patient with periodontitis.

Detailed description

Human cytomegalovirus (HCMV), Epstein-Barr virus (EBV) Human Herpes virus6 (HHV-6)

Interventions

None listed

Study design

Observational model

CASE_ONLY

Time perspective

CROSS_SECTIONAL

Eligibility

Sex/Gender

ALL

Age

18 Years to 80 Years

Healthy volunteers

Inclusion criteria

* Patient with peridontitis

Exclusion criteria

* Previous periodontal treatment in last 3 month * Toothbrushing disability

Design outcomes

Primary

Measure	Time frame	Description
The Prevelance Rate of the EBV, HCMV, HHV-6 in saliva	1 year	Check the EBV, HCMV, HHV-6 in saliva by PCR

Secondary

Measure	Time frame	Description
change outcomes EBV, HCMV, HHV-6 in saliva before and after toothbrushing	1 year	Check the EBV, HCMV, HHV-6 in saliva by RC-PCR before and after toothbrushing

Countries

Israel

Outcome results